Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
81 hedge funds and large institutions have $100M invested in Osiris Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 20 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 18
12% less funds holding
Funds holding: 92 → 81 (-11)
46% less capital invested
Capital invested by funds: $186M → $100M (-$86.3M)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
96% less call options, than puts
Call options by funds: $162K | Put options by funds: $3.83M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$2.78M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$1.58M |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$1.3M |
| 4 |
Renaissance Technologies
New York
|
+$995K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$503K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$3.78M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$2.19M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.87M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$1.77M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.39M |
OSIR Hedge Fund Activity: Q4 2015 in Review
81 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q4 2015, worth a combined $100M — down 46% from $186M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of OSIR and 10 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 30 added.
The largest buyer was Consonance Capital Management, adding an estimated $2.78M. The largest seller was Hood River Capital Management, exiting entirely with an estimated $3.78M sold.
- 81 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q4 2015, down from 92 in Q3 2015.
- Funds reported $100M of Osiris Therapeutics, Inc. Common Stock stock for Q4 2015, down 46% quarter-over-quarter.
- 10 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q4 2015 and 20 closed out, a net change of -10 holders.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q4 2015 was Consonance Capital Management, an estimated $2.78M added.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q4 2015 was Hood River Capital Management, an estimated $3.78M sold.
Based on aggregated 13F filings for Q4 2015.